B3GALT5 knockout alters gycosphingolipid profile and facilitates transition to human naïve pluripotency.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33087559.
- Also identified by DOI 10.1073/pnas.2003155117 and PMC identifier 7959494.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Conversion of human pluripotent stem cells from primed to naïve state is accompanied by altered transcriptome and methylome, but glycosphingolipid (GSL) profiles in naïve human embryonic stem cells (hESCs) have not been systematically characterized. Here we showed a switch from globo-(SSEA-3, SSEA-4, and Globo H) and lacto-series (fucosyl-Lc4Cer) to neolacto-series GSLs (SSEA-1 and H type 2 antigen), along with marked down-regulation of β-1,3-galactosyltransferase (B3GALT5) upon conversion to naïve state. CRISPR/Cas9-generated <i>B3GALT5-</i>knockout (KO) hESCs displayed an altered GSL profile, increased cloning efficiency and intracellular Ca<sup>2+</sup>, reminiscent of the naïve state, while retaining differentiation ability. The altered GSLs could be rescued through overexpression of B3GALT5. <i>B3GALT5-</i>KO cells cultured with 2iLAF exhibited naïve-like transcriptome, global DNA hypomethylation, and X-chromosome reactivation. In addition, <i>B3GALT5</i>-KO rendered hESCs more resistant to calcium chelator in blocking entry into naïve state. Thus, loss of B3GALT5 induces a distinctive state of hESCs displaying unique GSL profiling with expression of neolacto-glycans, increased Ca<sup>2+</sup>, and conducive for transition to naïve pluripotency.
Medical subject headings
- Cell Differentiation
- Galactosyltransferases
- Glycosphingolipids
- Pluripotent Stem Cells
- Stage-Specific Embryonic Antigens